Apyx Medical Inc

NASDAQ APYX

Data sourced from

and

Download Data

Apyx Medical Inc Retained Earnings To Equity Ratio 3 year CAGR for the Trailing 12 Months (TTM) ending March 31, 2024

Apyx Medical Inc Retained Earnings To Equity Ratio 3 year CAGR is NA for the Trailing 12 Months (TTM) ending March 31, 2024. The retained earnings to equity ratio measures the proportion of a company's retained earnings to its shareholders' equity. It is calculated by dividing the retained earnings by the shareholders' equity. This ratio provides insights into the company's reinvestment of earnings and the level of retained profits relative to shareholders' equity. A higher ratio suggests a higher proportion of earnings being retained for reinvestment or future distribution to shareholders. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.

Apyx Medical Inc Retained Earnings To Equity Ratio for the Trailing 12 Months (TTM) ending March 31, 2023 was -0.82, a -258.48% change year over year.
Apyx Medical Inc Retained Earnings To Equity Ratio for the Trailing 12 Months (TTM) ending March 31, 2022 was -0.23, a -590.96% change year over year.
Apyx Medical Inc Retained Earnings To Equity Ratio for the Trailing 12 Months (TTM) ending March 31, 2021 was 0.05, a -81.16% change year over year.
Apyx Medical Inc Retained Earnings To Equity Ratio for the Trailing 12 Months (TTM) ending March 31, 2020 was 0.25, a 669.77% change year over year.

NASDAQ: APYX

Apyx Medical Inc

CEO	Mr. Charles D. Goodwin II
IPO Date	Jan. 1, 1987
Location	United States
Headquarters	5115 Ulmerton Road, Clearwater, FL, United States, 33760
Employees	252
Sector	Healthcare
Industry	Medical devices

Description

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Key trends